Kairos Pharma, LTD. Business Finance Contracts & Agreements
13 Contracts & Agreements
- Exchange Agreements (1 contract)
- Loan Agreements (3)
- Note Agreements (3)
- Purchase Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (3)
- Purchase Agreement, dated November 12, 2024, by and between Kairos Pharma, Ltd. and Helena Global Investment Opportunities I Ltd (Filed With SEC on November 14, 2024)
- Common Stock Purchase Warrant issued to EF Hutton LLC, dated September 17, 2024 (Filed With SEC on September 17, 2024)
- Common Stock Purchase Warrant issued to Boustead Securities, LLC, dated September 17, 2024 (Filed With SEC on September 17, 2024)
- Underwriting Agreement between Kairos Pharma, Ltd. and Boustead Securities, LLC dated September 16, 2024 (Filed With SEC on September 17, 2024)
- Amendment to Loan Agreement, dated August 16, 2024, between the Company and Doug Samuelson (Filed With SEC on August 16, 2024)
- Amendment to Loan Agreement, dated August 16, 2024, between the Company and John S. Yu (Filed With SEC on August 16, 2024)
- Form of Loan Agreement, dated April 26, 2024, between the Company and Certain Officers (Filed With SEC on May 1, 2024)
- Form of Representatives Warrant (Filed With SEC on May 1, 2024)
- Form of Underwriting Agreement by and between Kairos Pharma, Ltd. and Boustead Securities, LLC, as representative of the underwriters (Filed With SEC on May 1, 2024)
- Form of Investor Rights and Lock-Up Agreement for 6% Convertible Notes (Filed With SEC on September 29, 2023)
- Form of 6% Convertible Note (Filed With SEC on September 29, 2023)
- Form of Subscription Agreement for 6% Convertible Notes (Filed With SEC on September 29, 2023)
- Share Exchange Agreement between Kairos Pharma, Ltd. and Enviro Therapeutics, Inc. dated June 3, 2021 (Filed With SEC on September 29, 2023)
